A total of five products were added in the month from five different asset managers: AllianceBernstein, Man, Pinebridge, Apollo, GI Partners, Monroe Capital and SLR CP.
CCR Monthly Approval Report – January 2024
February 6, 2024 by
Three mutual funds, one ETF and one alternative product gained CCR approval to kick off 2024. Sponsors gaining approval were UBS, Invesco and TrueBridge Capital Partners.
CCR Monthly Approval Report – December 2023
January 4, 2024 by
Barings, Gemcap, BNP Paribas, UBS andGlobal Infrastructure Partners were the fund sponsors gaining approval for new product
CCR Monthly Approval Report – November 2023
December 6, 2023 by
A total of 14 products were added in the month from the following asset managers: Vanguar, New Capital, Invesco, UTI Goldfinch, TowerBrook Capital Partners and Strategic Partners.
CCR Monthly Approval Report – October 2023
November 8, 2023 by
A total of six products were added in the month from six different asset managers: Franklin Templeton, Goldman Sachs, Impax, Jupiter, KPS Capital and Vanguard.
CCR Monthly Approval Report – September 2023
October 3, 2023 by
A total of five products were added in the month from four different brands: Franklin Templeton, Colchester, M&G, and Independencia.
Three players with active ETFs have taken positions
September 22, 2023 by
Following the CCR update to its Resolution 32 a couple of months ago, ETF managers have registered an offering of around 60 active products for pension funds.
CCR Monthly Approval Report – August 2023
September 7, 2023 by
JP Morgan, Dimensional, Franklin Templeton, DWS, Lazard, Morgan Stanley and AEA Investors were the fund sponsors gaining approval for new products in August.
CCR Monthly Approval Report – July 2023
August 4, 2023 by
A total of 27 products were added in the month from 10 different asset managers: American Century, Franklin Templeton, Comgest, Columbia Threadneedle, HSBC, Acadian, JPMorgan, Morgan Stanley, Invesco and KKR.
CCR Monthly Approval Report – June 2023
July 7, 2023 by
Mutual funds from Goldman, Man, Wellington and Moneda were approved in the month of June 2023.
